Premium
A novel de novo germline mutation Glu40Lys in AKT3 causes megalencephaly with growth hormone deficiency
Author(s) -
Takagi Masaki,
Dobashi Kazushige,
Nagahara Keiko,
Kato Mitsuhiro,
Nishimura Gen,
Fukuzawa Ryuji,
Narumi Satoshi,
Hasegawa Tomonobu
Publication year - 2017
Publication title -
american journal of medical genetics part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.064
H-Index - 112
eISSN - 1552-4833
pISSN - 1552-4825
DOI - 10.1002/ajmg.a.38099
Subject(s) - megalencephaly , germline , germline mosaicism , germline mutation , mutation , biology , cancer research , genetics , endocrinology , gene
Germline or somatic gain‐of‐function mutations in the v‐akt murine thymoma viral oncogene homolog 3 ( AKT3 ) have been reported to cause syndromic megalencephaly. We describe a novel germline mutation, p.Glu40Lys, in AKT3 . Phenotypically, the patient presented with megalencephaly with hypotonia, apparent connective tissue laxity, and growth hormone (GH) deficiency. To our knowledge, this is the first instance of a patient with megalencephaly with GH deficiency, harboring a germline de novo mutation in AKT3 . © 2017 Wiley Periodicals, Inc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom